GlaxoSmithKline Pharmaceuticals Limited Share Price NSE India S.E.
Equities
GLAXO
INE159A01016
Pharmaceuticals
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
2,619 INR | +0.96% | +7.75% | +37.99% |
Sales 2024 | 3.45TCr 41Cr | Sales 2025 * | 3.8TCr 46Cr | Capitalization | 45TCr 534.28Cr |
---|---|---|---|---|---|
Net income 2024 | 590Cr 7.07Cr | Net income 2025 * | 817.6Cr 9.8Cr | EV / Sales 2024 | 9.53 x |
Net cash position 2024 * | - 0 | Net cash position 2025 * | - 0 | EV / Sales 2025 * | 11.7 x |
P/E ratio 2024 |
55.8
x | P/E ratio 2025 * |
54.5
x | Employees | 3,680 |
Yield 2024 |
1.65% | Yield 2025 * |
1.15% | Free-Float | 24.42% |
1 day | +0.96% | ||
1 week | +7.75% | ||
1 month | +25.52% | ||
3 months | +20.50% | ||
6 months | +58.07% | ||
Current year | +37.99% |
Managers | Title | Age | Since |
---|---|---|---|
Bhushan Akshikar
CEO | Chief Executive Officer | 54 | 01/22/01 |
Juby Chandy
DFI | Director of Finance/CFO | - | 01/22/01 |
Simrat Sohal
CMP | Compliance Officer | - | - |
Members of the board | Title | Age | Since |
---|---|---|---|
Renu Sud Karnad
CHM | Chairman | 70 | 01/19/01 |
Manu Anand
BRD | Director/Board Member | 64 | 16/22/16 |
Director/Board Member | 74 | 30/15/30 |
Date | Price | Change | Volume |
---|---|---|---|
31/24/31 | 2,619 | +0.96% | 395,141 |
30/24/30 | 2,594 | +2.38% | 324,309 |
29/24/29 | 2,534 | +2.15% | 435,700 |
28/24/28 | 2,480 | +5.06% | 490,373 |
27/24/27 | 2,361 | -2.87% | 140,945 |
Delayed Quote NSE India S.E., May 31, 2024 at 05:13 pm IST
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+40.73% | 74TCr | |
+32.83% | 60TCr | |
-6.30% | 35TCr | |
+15.15% | 32TCr | |
+4.05% | 28TCr | |
+15.00% | 24TCr | |
-5.52% | 21TCr | |
+6.17% | 16TCr | |
-0.45% | 16TCr |
- Stock Market
- Equities
- GLAXO Stock
- GLAXO Stock